MedPath

Yonsei University

Yonsei University logo
🇰🇷South Korea
Ownership
Private
Established
1885-01-01
Employees
5K
Market Cap
-
Website
http://www.yonsei.ac.kr

OCT-based Machine Learning FFR for Predicting Post-PCI FFR

Not yet recruiting
Conditions
Fractional Flow Reserve, Myocardial
Tomography, Optical Coherence
First Posted Date
2024-04-02
Last Posted Date
2024-04-02
Lead Sponsor
Yonsei University
Target Recruit Count
82
Registration Number
NCT06341361

Study of Efficacy of Digital Cognitive Behavioral Therapy With Wearable Device for Insomnia

Not Applicable
Completed
Conditions
Insomnia
Interventions
Device: WELT-IP with wearable devices (Apple/galaxy watch. Oura ring)
First Posted Date
2024-04-01
Last Posted Date
2024-04-01
Lead Sponsor
Yonsei University
Target Recruit Count
30
Registration Number
NCT06339853
Locations
🇰🇷

Department of Psychiatry, Severance Hospital, Seoul,, Korea, Republic of

Impact of Preoperative Frailty and Cognitive Impairment on Postoperative Outcomes in Elderly Cardiac Surgery Patients

Completed
Conditions
Cardiovascular Diseases
First Posted Date
2024-03-26
Last Posted Date
2025-01-10
Lead Sponsor
Yonsei University
Target Recruit Count
447
Registration Number
NCT06330532
Locations
🇰🇷

Yonsei University Health system, Severance Hospital, Seoul, Korea, Republic of

Predictability of ANI (Analgesia Nociception Index) for Spinal Hypotension

Recruiting
Conditions
Cesarean Section
Spinal Anesthesia
Interventions
Other: observation
First Posted Date
2024-03-25
Last Posted Date
2024-03-27
Lead Sponsor
Yonsei University
Target Recruit Count
40
Registration Number
NCT06327165
Locations
🇰🇷

Yonsei University Health system, Severance Hospital, Seoul, Korea, Republic of

Exploring Approaches With Lower Targets of Blood Pressure and Lipid for Improving Renal Outcome in Advanced Chronic Kidney Disease

Not Applicable
Recruiting
Conditions
Chronic Kidney Diseases
Hypertension
Dyslipidemias
Interventions
Drug: Intensive control of SBP and intensive control of LDL-C
Drug: Standard control of SBP and intensive control of LDL-C
Drug: Intensive control of SBP and standard control of LDL-C
Drug: Standard control of SBP and standard control of LDL-C
First Posted Date
2024-03-20
Last Posted Date
2024-12-16
Lead Sponsor
Yonsei University
Target Recruit Count
642
Registration Number
NCT06322056
Locations
🇰🇷

Severance Hospital, Seoul, Korea, Republic of

The Appropriate Remifentanil Dose for Optimal Insertion of Laryngeal Mask Airway in Adult Patients During Induction of General Anesthesia Using Remimazolam.

Not Applicable
Recruiting
Conditions
Adult, Laryngeal Masks, Remimazolam, Remifentanil
Interventions
Device: Ambu Auragain for airway management
First Posted Date
2024-03-04
Last Posted Date
2024-03-04
Lead Sponsor
Yonsei University
Target Recruit Count
67
Registration Number
NCT06289829
Locations
🇰🇷

Severance Hospital, Seoul, Korea, Republic of

Comparison of the Coughing Frequency of Remimazolam Total Intravenous Anesthesia Versus Inhalational Anesthesia

Not Applicable
Completed
Conditions
Thyroid Neoplasm
Cough
Interventions
Drug: Total intravenous anesthesia with Byfavo
Drug: Inhalation anesthesia with Sevoflurane
First Posted Date
2024-02-23
Last Posted Date
2024-02-23
Lead Sponsor
Yonsei University
Target Recruit Count
106
Registration Number
NCT06275425
Locations
🇰🇷

Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, College of Medicine, Yonsei University,, Seoul, Korea, Republic of

Effect of Alfacalcidol on Muscle Function in Osteoporosis Patients

Phase 4
Not yet recruiting
Conditions
Sarcopenia
Interventions
First Posted Date
2024-02-22
Last Posted Date
2024-02-22
Lead Sponsor
Yonsei University
Target Recruit Count
340
Registration Number
NCT06272227
Locations
🇰🇷

Division of Endocrinology, Department of internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Korea, Republic of

Neoadjuvant Lazertinib With or Without Chemotherapy for Patients With EGFR-mutated Resectable Non-small Cell Lung Cancer

Phase 2
Not yet recruiting
Conditions
Non-small Cell Lung Cancer
Interventions
Drug: Lazertinib+Pemetrexed+Carboplatin
First Posted Date
2024-02-20
Last Posted Date
2024-02-20
Lead Sponsor
Yonsei University
Target Recruit Count
160
Registration Number
NCT06268210
Locations
🇰🇷

Severance hospital, Seoul, Korea, Republic of

The Effect of Post-operative Exercise in Gastric Cancer Patients: A Randomized Controlled Trial (RCT) Study

Not Applicable
Completed
Conditions
Gastric Cancer
Interventions
Behavioral: exercise
First Posted Date
2024-02-15
Last Posted Date
2025-03-11
Lead Sponsor
Yonsei University
Target Recruit Count
52
Registration Number
NCT06260293
Locations
🇰🇷

Department of Surgery, Yonsei University College of Medicine, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath